 ?您的位置：對(duì)照品 > 對(duì)照品 > 中檢所對(duì)照品 > |
|
|
|
| 產(chǎn)品基本信息 |
|
| 產(chǎn)品編號(hào)：T007405 |
| 產(chǎn)品名稱(chēng)：Taprenepag |
| 產(chǎn)品CAS：752187-80-7 |
| 規(guī)格含量：10mg |
| 產(chǎn)品價(jià)格：面議 |
| 聯(lián)系我們: |
 |
|
 |
|
|
| 產(chǎn)品詳細(xì)介紹 |
| 標(biāo)準(zhǔn)品編號(hào): |
T007405 |
| 名稱(chēng): |
Taprenepag |
| 別名: |
2-[3-[[[[4-(1H-Pyrazol-1-yl)phenyl]methyl](3-pyridinylsulfonyl)amino]methyl]phenoxy]acetic Acid; CP 544326; 2-(3-((N-(4-(1H-Pyrazol-1-yl)benzyl)pyridine-3-sulfonamido)methyl)phenoxy)acetic Acid; |
| CAS號(hào): |
752187-80-7 |
| 分子式: |
C??H??N?O?S |
| 分子量: |
478.52 |
| 類(lèi)別: |
Standards; Pharmaceutical/API Drug Impurities/Metabolites; |
| 應(yīng)用: |
Taprenepag is a selective EP2 receptor agonist administered as a topical ophthalmic solution against ocular hypertension. |
| 參考文獻(xiàn) |
|
|
|
|
|
|
